Next Article in Journal
Living with the Void: Coexistence, Adaptation, and Acceptance of Urban Emptiness
Previous Article in Journal
Evaluating Intersection Performance Under Land-Use-Generated Traffic Increases: A Turbo Roundabout Application
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine from an Urban Heterogeneity Perspective: A Multiple-Case Comparison Based on Innovation Clusters in China

School of Human Settlements and Civil Engineering, Xi’an Jiaotong University, Xi’an 710049, China
*
Author to whom correspondence should be addressed.
Urban Sci. 2026, 10(5), 234; https://doi.org/10.3390/urbansci10050234
Submission received: 1 February 2026 / Revised: 9 March 2026 / Accepted: 24 March 2026 / Published: 29 April 2026

Abstract

Shared pilot-scale bases enhance organizational efficiency and improve the success rate of transformation by leveraging spatial proximity among innovation actors, serving as a critical bridge between laboratory R&D and industrialization in biomedicine. Unlike the dominant models in mature markets such as Europe and the United States, which rely on in-house R&D by leading firms or marketized outsourcing, China has developed a government-guided, regionally adapted model of shared pilot-scale bases. This study refines the classification of innovation actors within innovation ecosystem theory and aims to reveal the spatial agglomeration patterns of these actors within shared pilot-based ecosystems and identify the dominant forces within them. Our analysis reveals that: (1) Shared pilot-scale bases anchor themselves in regions of high innovation concentration, representing government-guided agglomerations of diverse innovation actors. (2) Influenced by variations in local economic foundations, innovation resources, and policies, the innovation networks of shared pilot bases in different cities exhibit both functional and morphological similarities and differences. (3) Strategic placement around leading enterprises can rapidly steer regional innovation gradients and foster industrial aggregation through pilot-scale activities. This study can provide a theoretical basis for spatial policymaking in China’s biomedical industry and offer a typological reference for the layout of pilot-scale platforms within heterogeneous innovation ecosystems globally.

1. Introduction

Against the backdrop of the global biomedicine industry’s transition from follow-on innovation to original innovation [1], pilot-scale activities serve as a critical hub linking laboratory R&D with mass production [2,3]. They play a key role in bridging the “valley of death” in innovation and enhancing the efficiency of translating scientific and technological achievements [4,5]. As the physical and organizational platform for pilot-scale verification [6], pilot-scale bases are becoming increasingly vital within regional science and technology innovation systems. Their technological spillover capacity has become an important metric for measuring regional innovation capability [7,8,9]. However, for many regions transitioning toward indigenous innovation, the core challenge is to construct a pilot-scale system that is deeply compatible with their local innovation ecosystem [10,11]. There is an urgent need to optimize the spatial layout of pilot-scale facilities to effectively coordinate the heterogeneous demands of diverse local innovation actors, thereby improving the overall efficiency of the pilot-scale system.
The organizational models for constructing pilot-scale bases exhibit significant differences. In mature markets represented by Europe and the United States, development typically relies on in-house R&D by dominant enterprises or highly specialized contract research and manufacturing organizations [12,13,14]. This model is rooted in mature industrial ecosystems and deeply marketized, highly open innovation networks [15]. In contrast, countries with transitional innovation systems, represented by China, have explored a development path for shared pilot-scale bases characterized by “government guidance and multi-actor co-construction and sharing” [16,17,18]. This model can rapidly fill gaps in the innovation chain and lower the industrialization threshold for small and medium-sized enterprises. Its inherent logic is closely intertwined with local industrial ecosystem structures, policy orientation, agglomeration of innovation factors, and collaborative networks. Therefore, conducting an in-depth analysis of the spatial organization logic of such shared pilot-scale bases contributes to enriching and refining the theory and methodology of pilot-scale base construction.
Some scholars, drawing on theories of industrial clusters and innovation ecosystems, emphasize the importance of knowledge spillovers [19,20], collaborative cooperation among innovation actors [21,22,23], spatial agglomeration of innovation [24], and resource sharing [25]. Other studies focus on traditional locational factor analysis [26,27], such as the relationship with central urban areas, transportation accessibility [28,29], geographical proximity [30,31], and infrastructure provision [32,33]. The aforementioned studies provide an important foundation for understanding the spatial organization of innovation activities. However, within the theoretical and practical context of “fostering industrial aggregation through pilot-scale activities”, existing research still exhibits three key limitations when explaining the spatial organization logic of such platforms in the biomedical field. First, there is a limitation in the classification of innovation actors. Although innovation ecosystem research regards “actors” as core elements, the classification of these actors is often overly generalized. Existing pilot-scale studies are primarily based on in-house research and development models led by Western enterprises or mature outsourcing models, and their theoretical presuppositions do not necessitate a functional differentiation of innovation actors. However, transitional innovation countries, represented by China, must systematically integrate differentiated research and development needs, knowledge sources, and risk-bearing capacities, thereby creating an urgent need for the functional differentiation of innovation actors [34]. Second, there is a limitation concerning proximity mechanisms. The theory of “multi-dimensional proximity” in economic geography posits that, in addition to geographical proximity, factors such as cognitive proximity, institutional proximity, and social proximity also influence innovation cooperation. In the practice of shared pilot-scale bases, the sensitivity of demand-side actors, knowledge sources, and service providers to proximity varies significantly. Their spatial coupling logic extends far beyond simple agglomeration, necessitating the construction of a corresponding spatial analysis framework [35]. Third, there is a limitation in research methods. The theory of “institutional thickness” emphasizes that regional success depends not only on the agglomeration of enterprises, but also on the institutional environment that supports innovation and its interactive networks. Existing research primarily relies on single-case analyses of specific cities or parks. However, in contexts where regional institutions and industrial foundations differ significantly, understanding the spatial practices of shared pilot-scale bases urgently requires cross-case comparative research that integrates multi-source geospatial data [36,37]. The aforementioned theoretical perspectives and their manifestations in different Chinese cities can be summarized in Table 1, which reveals the spatial structure characteristics of Beijing, Shanghai, and Wuhan, thereby laying the foundation for the comparative analysis of this study.
To address these research gaps, this paper focuses on the spatial organization logic and typology of shared pilot-scale bases in biomedicine within the context of “fostering industrial aggregation through pilot-scale activities”. As a representative of catching-up economies, China—driven by a synergy of government and market forces, leveraging its ultra-large market, vibrant domestic innovation, and unique institutional environment—provides a crucial case for studying the organizational logic of innovation infrastructure in non-mature markets. In this study, we first establish a functional classification system for innovation actors based on their core roles in the pilot-scale process. Subsequently, we select three leading cities in China’s biomedicine industry development for cross-case analysis. By integrating POI data and Geographic Information System (ArcGIS 10.7) spatial analysis methods, this study aims to: (1) reveal the spatial agglomeration characteristics of innovation actors within shared pilot-scale base ecosystems; (2) analyze the functional and morphological differences in innovation networks based on the spatiotemporal evolution of enterprise registrations; and (3) identify the types of innovation actors that play a decisive role in the evolution of regional innovation ecosystem structures.
Based on innovation ecosystem theory and the perspective of urban heterogeneity, this study proposes the following hypotheses:
Hypothesis 1 (H1). 
The Spatial Structure Hypothesis. Cities with a stronger knowledge base exhibit a more polycentric spatial structure than cities with a weaker knowledge base.
Hypothesis 2 (H2). 
The Agglomeration Degree Hypothesis. Policy-driven latecomer regions exhibit a higher degree of spatial agglomeration of innovation actors than market-driven mature regions.
Hypothesis 3 (H3). 
The Evolutionary Path Hypothesis. Market-driven mature regions follow a more gradual evolutionary path with greater spatial flexibility, whereas policy-driven latecomer regions follow a more rapid, leapfrog evolutionary path characterized by structural lock-in.
These hypotheses focus on the interaction between the spatial behavior of innovation actors and the regional institutional environment, which is precisely the core issue addressed by the Regional Innovation System (RIS) theory. As the overarching analytical framework for this study, RIS theory emphasizes that regional innovation performance depends on the networks of knowledge creation, diffusion, and application formed by multiple actors within a specific institutional environment. This paper engages in a dialog with RIS theory from three dimensions: First, addressing the vagueness of actor classification within RIS, we construct a multi-dimensional classification framework for core populations in biomedicine based on pilot-scale functions (Table 2), subdividing actors into five functional communities and thereby deepening the understanding of actor heterogeneity. Secondly, RIS emphasizes actor interaction and knowledge flow; this study employs kernel density analysis, spatiotemporal evolution analysis, and core-periphery analysis to transform abstract interactive relationships into observable spatial patterns, revealing the spatial structure and functional differentiation of innovation networks. Thirdly, RIS focuses on the influence of the institutional environment on actor behavior; through a cross-case comparison of the three cities, this study identifies how three institutional forces—market, knowledge, and policy—differentially influence the spatial morphology and evolutionary paths of innovation networks, establishing a testable link between institutional thickness and spatial form. In summary, using RIS as a foundational framework and employing functional subdivision of actors, multi-dimensional spatial analysis, and cross-case comparison, this paper aims to deepen the understanding of the spatial dimension of RIS and provide a theoretical explanation and empirical basis for the positioning of shared pilot-scale bases within regional innovation systems.
To systematically test the above hypotheses, this study adopts an integrated multi-method analytical strategy: Hypothesis 1 (H1) is tested by comparing the kernel density maps of biomedical enterprises across the three cities to reveal the morphological differences in their spatial structures; Hypothesis 2 (H2) is evaluated by measuring the degree of spatial agglomeration of innovation actors, particularly leading enterprises, using core-periphery analysis and concentration ratios; Hypothesis 3 (H3) is examined through a three-phase spatiotemporal evolution analysis based on enterprise registration data to uncover the differentiated evolutionary paths and their driving mechanisms across the three cities.

2. Materials and Methods

2.1. Core Concept Definition: Spatial Organization Logic

Before proceeding with the specific analysis, it is necessary to clearly define the core concept of this study: “spatial organization logic”. As used in this research, “spatial organization logic” refers to the comprehensive manifestation of the spatial distribution patterns, agglomeration characteristics, interaction modes, and dynamic evolutionary laws of various innovation actors centered around the key facility of shared pilot-scale bases within a specific urban innovation ecosystem. These patterns are shaped by functional linkages, multi-dimensional proximity demands, and institutional environment constraints. Specifically, this logic encompasses three interrelated analytical dimensions: the first is spatial structure, referring to the distribution patterns of innovation actors at the urban scale, such as unipolar polarization or polycentric networking models; the second is functional differentiation, reflecting the spatial division of labor and synergistic relationships among different types of actors—that is, the spatial configuration of the innovation value chain; the third is the evolutionary path, revealing the dynamic process of industrial spatial pattern change over time and its core driving forces (market mechanisms, knowledge spillovers, policy interventions, etc.). Through a systematic analysis of the aforementioned dimensions, this paper aims to reveal the common patterns of spatial organization in shared pilot-scale bases alongside characteristics of urban heterogeneity, thereby providing a theoretical basis for their planning and construction.
Based on the above definition, the empirical analysis of this study operationalizes these three dimensions as follows: (1) Spatial structure: Visualized through kernel density analysis to reveal the distribution patterns of innovation actors at the urban scale; (2) Functional differentiation: Examined through category-specific kernel density analysis to uncover the differentiated spatial characteristics and complementary relationships among various types of actors; (3) Evolutionary path: Traced through phased kernel density maps based on enterprise registration years to illustrate how spatial patterns change over time and how market, knowledge, and policy forces shape these trajectories. Together, these three dimensions construct a holistic understanding of how shared pilot-scale bases are embedded within and co-evolve with their regional innovation ecosystems.

2.2. Study Area

Adhering to the principles of typicality, diversity, and systematicity, this study selects three cities—Beijing, Shanghai, and Wuhan—as research cases (Figure 1). These cities are not only major agglomeration hubs for China’s biomedicine industry but also represent three distinct regional development paradigms and spatial formation logics. This provides a diverse empirical foundation for systematically revealing the spatial organization logic of shared pilot-scale bases.
Beijing exemplifies a powerful dual-driven model of knowledge and policy. It hosts the nation’s top universities and research institutes alongside a strong national-level policy support network, with its industrial ecosystem characterized by knowledge creation and original innovation sourcing. Furthermore, under the coordinated development strategy of the metropolitan area, its industrial space shows a trend of multi-point diffusion into suburbs and networked interconnection. Shanghai serves as a model driven by market forces and globalization. It concentrates a large number of multinational pharmaceutical R&D centers, leading domestic listed enterprises, and a mature venture capital market, forming a highly export-oriented, market-dominated, and polarized innovation ecosystem. Wuhan represents a latecomer catch-up mode driven by strong policy planning. Strategic planning and sustained resource allocation for national-level industrial bases like the Optics Valley Biolake have enabled Wuhan to achieve rapid agglomeration of its biomedicine industry within a relatively short period. Its spatial structure exhibits a strong policy orientation.
The marked differences among these three models help us move beyond simplistic replication of any single successful experience. Consequently, they allow us to uncover the agglomeration characteristics of innovation actors’ spatial structures under varying resource endowments, innovation resources, and policy orientations, as well as their impact on the spatial organization of shared pilot-scale bases.

2.3. Data Sources

2.3.1. Core Population Multidimensional Classification Framework

To precisely analyze the association between various innovation actors and the pilot-scale process, as well as their spatial logic, this study constructs a core population classification framework for biomedicine. It draws on China’s Strategic Emerging Industries Classification (2018) and the Pharmaceutical Industry Development Plan Guidelines, yet places greater emphasis on classification from the perspective of pilot-scale functionality. The aim is to accurately capture the differentiated positioning of different types of actors within the pilot-scale process. Specifically, based on the innovation value chain, this framework categorizes diverse innovation actors into core functional groups comprising higher education institutions, scientific research institutes, and five types of enterprises (Table 2).

2.3.2. Data Sources and Processing

This study primarily uses Point of Interest (POI) data to identify and locate the spatial entities of biomedical enterprises. Based on the Application Programming Interfaces of the Gaode Map and Baidu Map open platforms, we crawled the initial Point of Interest data related to biomedicine within the study areas of the three cities. To ensure search effectiveness within the Chinese context, keywords were searched in Chinese, specifically including: “Pharmaceutical”, “Biotechnology”, “Medical R&D”, “Medical Devices”, “Biomedicine”, “Drug R&D”, “Pharmaceutical Technology”, and “Medical Laboratory”. Each data point includes attributes such as company name, latitude and longitude coordinates, detailed address, and industry category.
To ensure data quality, we performed a data cleaning process on the initial dataset. First, we unified the coordinate systems from different sources to the WGS 1984 geographic coordinate system using ArcGIS. Second, we removed duplicate records based on name and address, and excluded records with invalid or severely incomplete address information. Finally, we imported the processed list of enterprises into the enterprise information query platform “Qichacha”. A manual review and precise screening were then conducted based on the “Business Scope” field in their industrial and commercial registration information, in conjunction with the Strategic Emerging Industries Classification (2018).
The inclusion and exclusion criteria for manual verification were as follows: (1) Inclusion criteria: The business scope explicitly includes core biomedical research and development and production activities such as “drug R&D”, “biological product manufacturing”, “pharmaceutical intermediate synthesis”, “clinical trial services”, “medical device production”, and “diagnostic reagent development”; or the business scope involves providing key technical services, equipment, and consumables supply for the aforementioned activities. (2) Exclusion criteria: Enterprises whose business scope primarily involves cosmetics, health foods, food additives, feed, agricultural biotechnology (e.g., fertilizers, pesticides), and other fields with low relevance to the core biomedical industry; enterprises with zero employees enrolled in social insurance; enterprises with vague business scope descriptions whose core business could not be verified through their official websites or public information. For enterprises whose business scope covered both inclusion and exclusion categories, judgment was made based on the proportion of their main business; if the core business fell within the scope of biomedical R&D and production, the enterprise was retained.
After following the above procedures, we obtained a total of 5176 valid biomedical enterprise POI entries: 1656 for Beijing, 2528 for Shanghai, and 992 for Wuhan (Table 3).

2.4. Methods

2.4.1. Basis for Selection of Analytical Methods

To systematically address the three research questions posed in this study, a methodological chain was formed by employing kernel density analysis, spatiotemporal evolution path analysis, and core-periphery structure analysis, respectively. The selection of methods followed a “problem-oriented” principle and was linked to the corresponding research questions.
To reveal the static spatial agglomeration characteristics of innovation actors within shared pilot-scale bases, a density measurement method capable of identifying industrial spatial patterns is required. Kernel Density Estimation, as a non-parametric statistical method, does not presuppose a spatial distribution model and can generate a continuous density surface directly from point data. It is a mature tool for identifying industrial agglomeration hotspots and spatial structure morphologies. Compared to point density analysis or the nearest neighbor index, KDE is more capable of smoothly and intuitively presenting complex spatial patterns such as polycentric networks and unipolar radiation, thus making it the preferred method for static spatial pattern analysis.
To analyze the evolutionary differences in the function and morphology of innovation networks, it is necessary to introduce a temporal dimension to characterize the dynamic evolution of spatial patterns. This study employs phased spatiotemporal evolution path analysis, dividing the study period into three phases consistent with key policy milestones, and conducting kernel density analysis on enterprise point locations for each phase. This method can reveal how driving forces such as markets, knowledge, and policy restructure spatial patterns over time, effectively capturing the path dependence and discontinuous characteristics of spatial evolution, and is superior to a single static cross-sectional comparison.
To identify the types of innovation actors that play a decisive role in the evolution of the regional innovation ecosystem, it is necessary to identify high-level actors within the innovation system and their spatial configuration characteristics. This study focuses on leading enterprises to conduct core-periphery structure analysis. By spatially overlaying the locations of leading enterprises identified from authoritative rankings with the city-wide enterprise heat maps and the locations of pilot-scale bases, it visually presents the spatial gradient of innovation capacity. This analytical framework draws on the logic of growth pole theory and the core-periphery model, transforming the abstract concept of capacity into quantifiable spatial statistical characteristics. It is used to verify whether leading enterprises constitute the “growth pole” of regional innovation and to reveal the spatial correlation between the siting of pilot-scale bases and high-level demands.
These three methods approach the analysis from the three dimensions of static pattern, dynamic evolution, and capacity gradient, respectively, forming a complementary analytical chain that collectively serves the understanding of shared pilot-scale bases.

2.4.2. Spatial Agglomeration and Pattern Analysis

Kernel Density Estimation (KDE) is a non-parametric statistical density estimation technique that does not rely on specific mathematical distributions or any modeling assumptions of the data [38]. It calculates the density of point or line features within their surrounding neighborhoods using a spatial dispersion formula, thereby generating a continuous surface. This helps determine the degree of agglomeration and the distribution pattern of point data [39,40]. A higher kernel density value indicates a more concentrated distribution of the studied objects, making specific spatial characteristics more pronounced [41].
Therefore, this study employs kernel density analysis to reveal the static spatial structure of the innovation ecosystem. After importing all POI point data, we used a Gaussian kernel function for computation to generate a continuous density surface. This visualization clarifies the spatial distribution of hotspots, coldspots, and functional agglomeration areas of various actors.
The calculation formula is as follows:
f ( x ) = 1 n r i = 1 n k ( d i x r )
where f(x) denotes the kernel density value at location x; n represents the total number of biomedical enterprise POI samples; k is the kernel function; dix is the distance from sample point I to location x; and r is the search radius, which is the key parameter determining the smoothness of the output.
Two points need to be clarified regarding the potential impact of category overlap on the kernel density results: First, the enterprise classification statistics in Table 2 employ duplicate counting (i.e., if a single enterprise is involved in multiple business categories, it is counted separately in each relevant category). This approach is adopted to reflect the compositional structure of enterprises across different functional communities from a quantitative perspective. However, the kernel density analysis utilizes independent enterprise points, meaning each enterprise participates in the calculation as a single spatial unit, with unique latitude and longitude coordinates, and without duplication. Therefore, overlaps in the functional classification of enterprises do not affect the spatial estimation results of the kernel density.
Second, regarding the robustness considerations for bandwidth selection. The results of Kernel Density Estimation are highly sensitive to the choice of search radius (bandwidth): an excessively large bandwidth can lead to over-smoothing of the density surface, obscuring local agglomeration characteristics; an excessively small bandwidth can produce a fragmented distribution, making it difficult to identify the overall spatial pattern. To balance this trade-off, this study referenced the optimal bandwidth selection rule for the Gaussian kernel function proposed by Silverman (1986), calculating the initial bandwidth based on the standard deviation of the spatial distribution of biomedical enterprise POI points in each city. Subsequently, considering the actual spatial scale and point density distribution characteristics of the study areas, density surfaces under different bandwidths (3 km, 5 km, 8 km) were compared through multiple trials. Ultimately, the bandwidth value that could clearly present the main agglomeration areas while maintaining spatial continuity was selected (5 km for Beijing, Shanghai, and Wuhan). This bandwidth was kept consistent across the three cities to ensure comparability in the cross-city analysis. Although data-driven techniques such as cross-validation were not employed, the robustness of the results has been tested to a certain extent through the comparison of multiple bandwidth trials—the locations of the main agglomeration cores remained stable under different bandwidths, with only differences in the smoothness of the agglomeration ranges.

2.4.3. Spatiotemporal Evolution Path Analysis

To dynamically analyze the evolution of industrial spatial patterns, this study employs spatial analysis tools to investigate the spatiotemporal evolutionary characteristics of urban industrial development [42,43]. Based on key policy milestones in the development of China’s biomedical industry, we divided the study period into three phases: 2000–2008 (Industry Germination Period), 2009–2016 (Rapid Expansion Period), and 2017–2024 (Innovation and High-Quality Development Period). The staging criteria are as follows:
(1) The year 2008 serves as the dividing line between the first and second phases, based on the official launch of the “Major New Drug Creation” Science and Technology Major Project in that year. This project provided centralized central government funding to support new drug R&D and pilot-scale processes, marking the industry’s transition from spontaneous exploration to national strategic direction. Prior to this, the industry was in a germination period, characterized by a small number of enterprises, scattered distribution, and R&D activities primarily reliant on universities and research institutes.
(2) The year 2016 serves as the dividing line between the second and third phases, based on the intensive implementation of a series of policies related to the reform of drug review and approval systems. In 2015, the State Council issued the Opinions on Reforming the Review and Approval System for Drugs and Medical Devices. Subsequently, in 2016, policies such as the Generic Drug Consistency Evaluation and the pilot program for the Marketing Authorization Holder system were implemented. These reforms clarified the responsible entities for pilot-scale processes and accelerated the launch of new drugs, stimulating rapid growth among innovative drug R&D and platform service enterprises. This drove the industry into a period of rapid expansion, marked by a surge in the number of enterprises and the emergence of spatial agglomeration effects.
(3) The period from 2017 to 2024 is defined as the innovation and high-quality development phase, corresponding to a policy shift from quantitative expansion to qualitative improvement. In 2017, China joined the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. In 2019, the new Pharmaceutical Administration Law was implemented. In 2020, the drug registration classification reform was enacted. These developments propelled the industry’s transformation toward original innovation, further highlighting the strategic importance of the pilot-scale stage.
Based on the aforementioned staging, spatial agglomeration analysis was conducted on the enterprise POI data for each phase separately. By comparing the spatial displacement, morphological changes, and intensity variations in the kernel density heat maps, the evolutionary patterns of the industrial spatial structure were interpreted.

2.4.4. Analysis of Innovation Capacity Hierarchy and Core-Periphery Structure

To examine the hierarchical structure of innovation actors and its potential influence on the spatial organization of pilot-scale bases, this study focuses on leading enterprises within the corporate population. We integrated authoritative rankings, such as the 2025 China Pharmaceutical Industry Comprehensive Competitiveness Top 100 List, with corporate geographic information data to identify the locations of leading enterprises. Using ArcGIS spatial analysis methods, we visualized their agglomeration hotspots, thereby delineating the core-periphery capacity gradient in each city. By conducting multi-layer overlay and correlation analysis of the leading enterprise agglomeration map, the heat map of overall enterprise distribution, and the spatial locations of known pilot-scale bases, we explored the spatial distribution characteristics of leading enterprise clusters.

2.4.5. Multi-Case Comparison

After completing the spatial analysis for individual cases, we conducted a cross-case comparison focusing on spatial structure, spatiotemporal evolution paths, and the capacity gradient of the industrial ecosystem. We analyzed their commonalities and differences in depth to elucidate the spatial organization logic of shared pilot-scale bases under different innovation ecosystem models. From this comparison, we distilled construction patterns with typological significance. On this basis, the empirical findings from the three cities were examined against the three theoretical hypotheses outlined above, aiming to assess whether the theoretical associations between different driving modes and spatial organization characteristics are supported by empirical evidence.

3. Results

3.1. Commonalities and Differences in the Spatial Agglomeration Patterns of Diverse Innovation Actors

Kernel density analysis reveals significantly differentiated spatial structure patterns among the core populations of the biomedical innovation ecosystems in Beijing, Shanghai, and Wuhan. Their core characteristics and driving mechanisms are summarized in Table 4.

3.1.1. Beijing: Functional Differentiation and Synergy Under a Polycentric Network Structure

Kernel density analysis indicates that the spatial distribution of biomedical enterprises in Beijing exhibits a distinct polycentric and networked structure. Two high-density agglomeration zones have formed, with the northern region (Haidian and Changping) and the southern region (Daxing and Tongzhou) serving as the core areas (Figure 2). Notably, the Zhongguancun Life Science Park, the Daxing Biomedical Industry Base, and the Yizhuang Pilot-Scale Platform are all located within these high-value enterprise agglomeration zones, demonstrating a high degree of spatial synergy between the layout of pilot-scale facilities and industrial clustering.
Further classification-specific kernel density analysis reveals a clear functional differentiation pattern. R&D-driven enterprises are highly concentrated in the northern region, forming tight spatial coupling with universities and research institutes. This confirms the fundamental influence of knowledge spillover and geographic proximity on R&D location (Figure 3a). Platform and service-oriented enterprises show a dual-core agglomeration in Changping and Daxing, respectively, connecting with R&D and industrialization demands (Figure 3b). Core tools and material suppliers exhibit an embedded distribution pattern, staying close to innovation-active zones (Figure 3c). Medical device and diagnostic equipment enterprises form multiple hotspots in areas such as Daxing and Changping (Figure 3d). Pharmaceutical circulation service-oriented enterprises are mainly distributed in transportation hubs like Shunyi and Tongzhou, showing appropriate spatial separation from R&D and manufacturing activities (Figure 3e). Overall, this pattern demonstrates the functional synergy characterized by “R&D in the north, industrialization in the south, embedded services, and spatially separated markets”.
The aforementioned spatial structural features result from the combined effects of Beijing’s substantial knowledge base, the industrial spatial restructuring guided by the “non-capital function relocation” policy, and market mechanisms. Quantitative analysis of enterprise types further indicates (Figure 3f) that Beijing’s biomedical enterprises have formed an industrial structure dominated by R&D-driven activities, complemented by platform services. This functionally supports and reinforces the stability and synergistic evolution of its polycentric, networked spatial system.

3.1.2. Shanghai: Moderate-to-High-Density Polarization and Functional Complementarity Under a Unipolar Radial Structure

The spatial distribution of enterprise entities exhibits a highly unipolar agglomeration pattern. Kernel density analysis results indicate that the city’s primary R&D and pilot-scale activities are heavily concentrated in the Pudong New Area, while Minhang, Fengxian, and Xuhui districts have formed functionally complementary secondary agglomeration zones (Figure 4).
Category-specific kernel density analysis reveals that R&D-driven enterprises are highly concentrated in Zhangjiang, forming a robust capability for original innovation (Figure 5a). Platform and service-oriented enterprises exhibit a linked “front-end research, back-end production” layout between Pudong and Fengxian (Figure 5b), reflecting the efficiency optimization of R&D and production service links based on land costs and industrial chain coordination under market forces. Core tool and material supply enterprises are distributed in close proximity to R&D and pilot-scale bases (Figure 5c). Medical device and diagnostic equipment enterprises show significant agglomeration in both Minhang and Pudong (Figure 5d). Pharmaceutical circulation service enterprises are primarily located in commercial hub areas such as Xuhui and Minhang. Overall, this presents a globally synergistic characteristic of “Pudong-led, multi-district collaboration, functional complementarity, and market dominance” (Figure 5e).
Quantitative analysis of enterprise types indicates that Shanghai’s biomedical industry exhibits a dual-core orientation of strong R&D-driven and medical device sectors. Its scale ranks first among the three cities, reinforcing the centripetal force and multifunctionality of its unipolar radial spatial configuration from an industrial structure perspective (Figure 5f).

3.1.3. Wuhan: Policy-Driven and Functionally Integrated Development Under a Single-Core Agglomeration Structure

The industrial space of the Wuhan metropolitan area presents a “point-axis” pattern, characterized by a “dispersed at a macro scale yet concentrated locally” distribution for manufacturing and a centralized layout for producer services. Its biomedical industry space is highly concentrated at the border between Hongshan District and Jiangxia District, forming a high-density polar nucleus centered around the Optics Valley Biolake (Figure 6).
Detailed analysis reveals that R&D-driven enterprises (Figure 7a) and platform and service-oriented enterprises (Figure 7b) show a high degree of spatial overlap in and around the core area of the Optics Valley Biolake. This demonstrates that under strong policy guidance, start-ups, R&D institutions, and service platforms have been concentrated into specific spaces to rapidly build an innovation ecosystem. Core tool and material supply enterprises are arranged around this core area (Figure 7c). Medical device and diagnostic equipment enterprises are also highly reliant on this core zone (Figure 7d). Pharmaceutical circulation service enterprises are concentrated in traditional transportation hubs such as Hanyang District (Figure 7e). Overall, this reflects the policy-driven spatial characteristics of “highly concentrated single-core agglomeration, functional zoning, and axial extension”. This spatial structure is a typical outcome of local governments achieving rapid industrial element agglomeration and spatial restructuring within a relatively short period through the strategic planning and sustained resource allocation focused on the “Optics Valley Biolake”.
Quantitative analysis of enterprise types indicates that the overall scale of Wuhan’s biomedical enterprises is relatively small, with the medical device sector showing relative dominance. However, supporting segments such as platform and service-oriented and core tool and material supply enterprises remain underdeveloped. Furthermore, over 70% of core enterprises are concentrated in the Optics Valley Biolake, reflecting the inherent industrial structural characteristics and dependency path of its “policy-guided single-core agglomeration” spatial configuration (Figure 7f).

3.1.4. Commonality and Divergence Findings

The commonality lies in the fact that all three cities have formed innovation populations primarily composed of R&D-driven and medical device enterprises. However, influenced by differences in their dominant driving mechanisms, the three cities exhibit distinct spatial structural morphologies: Beijing presents a polycentric network structure shaped by the long-term interaction between knowledge and policy; Shanghai displays a unipolar radial structure driven by the strong coupling of global resources and strategic policy; Wuhan features a single-core agglomeration structure under strong policy intervention, reflecting a typical trajectory of strategic catch-up by a latecomer region. This indicates that cities vary considerably in their economic foundations, innovation resources, and policy orientations [44]. The spatial organization of pilot bases must therefore align with differentiated geographical-functional proximity configurations shaped by distinct driving forces. This aligns with the theoretical expectation of H1 that knowledge-driven cities tend toward polycentric development.

3.2. Commonality and Differences in the Spatiotemporal Evolution Paths of Enterprise Populations

Enterprises have different development needs at various stages of their life cycle. Drawing on the business registration dates of enterprises, this study analyzes their spatial agglomeration characteristics in phases. This approach reveals the dynamic restructuring process of the biomedical industry’s spatial patterns in the three cities and the core driving forces behind it (Table 5).

3.2.1. Beijing: Progressive Evolution from Peripheral Industrial Bases to a Polycentric Collaborative Network

Spatiotemporal analysis reveals a progressive, multi-driven evolutionary path for Beijing’s industrial spatial pattern (Figure 8a). During the Industry Germination Period (2000–2008), density hotspots emerged in peripheral industrial bases such as Daxing and Changping, reflecting the industry’s early dependence on low-cost land and basic manufacturing functions. In the Rapid Expansion Period (2009–2016), enterprise density increased markedly in knowledge-core districts like Haidian and Chaoyang. These areas formed close linkages with the northern university cluster, giving initial shape to a polycentric pattern. During the Innovation and High-Quality Development Period (2017–2024), the various centers continued to develop and strengthen their connections through infrastructure and policy corridors. This ultimately resulted in a mature evolutionary model characterized by “peripheral incubation-center polarization-network synergy”. This pathway stems from the long-term interplay of market self-organization, proactive planning guidance, and endogenous knowledge dynamics. It demonstrates considerable path elasticity and adaptability.

3.2.2. Shanghai: From Strategic Unipolar Initiation to Functional Integration of a Global City-Region

The analysis results (Figure 8b) illustrate the evolutionary trajectory of Shanghai’s industrial space shaped by the dual logics of market forces and policy. In the early stage, the density peak was highly concentrated in Zhangjiang, Pudong, which typifies how national strategy (the development of Pudong) powerfully molded the initial spatial structure. During the rapid expansion period, industrial activities dispersed to areas such as Minhang, Fengxian, and Songjiang alongside market growth and cost gradients, forming several functionally complementary secondary hotspots. This diffusion reflects the spatial deconstruction and subsequent re-agglomeration of the industrial chain under market mechanisms. In the innovation and high-quality development period, the spatial pattern evolved into an integrated structure with Pudong at the core, leading to specialized collaboration across multiple districts. This evolution embodies the logic of “strategic initiation, market expansion, and functional integration”. This process is deeply embedded within the global industrial division of labor, with its pace and direction significantly influenced by international capital flows and technological change.

3.2.3. Wuhan: From Dispersed Layout to Policy-Anchored Unipolar Leapfrog Development

The analysis results (Figure 8c) visually illustrate the rapid restructuring of Wuhan’s industrial space under strong policy intervention. In the early stage, enterprise locations were dispersed, lacking high-capacity agglomeration zones. Following the key policy milestone of planning and constructing the Optics Valley Biolake in 2008, various industrial factors rapidly concentrated in this area. Since 2017, Wuhan has formed a unipolar dominant pattern centered on the Optics Valley Biolake. Overall, the city’s biomedical industry exhibits an evolutionary characteristic of “dispersed germination-policy-driven-structural lock-in”. This pathway highlights how a later-developing region, during a specific historical window, actively shapes and firmly locks in its innovation geography through government-led investment in innovation infrastructure and industrial policies, resulting in an extremely rapid evolution.

3.2.4. Commonality and Divergence Findings

The enterprise populations in all three cities share a common process of evolving from relative dispersion to spatial agglomeration, affirming the fundamental principle of agglomeration economies. The core divergence lies in the composition of driving forces and the elasticity of evolutionary paths. The evolution of both Beijing and Shanghai integrates multiple drivers—market forces, knowledge, and policy—exhibiting progressive and adaptive characteristics with relatively malleable spatial structures. In contrast, the evolution of Wuhan is dominated by strong policy at critical junctures, demonstrating leapfrog and interventionist features, with its spatial structure becoming highly solidified within a short timeframe. This difference in evolutionary paths is consistent with the expectation of Hypothesis H3 regarding the divergence in evolutionary trajectories between market-driven and policy-driven regions, thereby supporting this hypothesis. This difference imposes distinct requirements on the planning timeline for pilot-scale bases: the former requires built-in flexibility to adapt to network evolution, whereas the latter necessitates close synchronization with the construction cycle of the core platform.

3.3. Commonalities and Differences in the Core-Periphery Capacity Gradient

By integrating the spatial distribution of leading enterprises identified through authoritative rankings such as the 2025 China Pharmaceutical Industry Comprehensive Competitiveness Top 100 List, this study reveals the differences in capacity gradients across the innovation ecosystems of the three regions. The distribution of leading enterprises across various concentric zones within each city intuitively reflects the spatial imbalance of regional innovation energy (Table 6).

3.3.1. Beijing: A Flattened Tiered Structure with Multi-Polar Interaction

The spatial distribution of leading enterprises (Figure 9a) aligns with the city’s polycentric network structure, forming a flattened tiered structure characterized by multi-polar interaction. Changping District (home to Zhongguancun Life Science Park) and Daxing District serve as the two primary core poles, collectively accounting for approximately 47.2% of the leading enterprises. Districts such as Haidian and Fangshan constitute important secondary poles. This distribution indicates that Beijing’s high-concentration innovation areas are not centered on a single geographic point. Instead, they are dispersed across multiple nodes, each with specialized functions. These nodes form a synergistic network through the flow of talent, technological collaboration, and supply chains.

3.3.2. Shanghai: A Steep Tiered Structure with a Unipolar Core Leadership

The analysis results (Figure 9b) indicate that Shanghai exhibits a prominent unipolar core leadership structure. Pudong New Area (particularly Zhangjiang) concentrates the vast majority (65.9%) of the city’s leading enterprises, demonstrating a capacity level significantly higher than other regions. Districts such as Minhang, Xuhui, and Songjiang form specialized secondary nodes, while the central urban area serves as a peripheral supplement.

3.3.3. Wuhan: A Polarized Tiered Structure with Single-Core Dominance

The analysis results (Figure 9c) show that Wuhan’s leading enterprises are highly concentrated in the single core of the Optics Valley Biolake, forming a polarized pattern. Although some enterprises are distributed in areas such as Hanyang District, their capacity levels differ significantly from those in the core area. This reflects the highly uneven spatial allocation of innovation resources under strong policy shaping.

3.3.4. Commonality and Divergent Features

The study finds that the pilot-scale bases in all three cities tend to locate in areas with a high concentration of leading enterprises, in order to meet urgent and intensive demands such as process scale-up, testing, inspection, and clinical validation. The core difference lies in the following: The steep gradients in Shanghai and Wuhan concentrate pilot-scale demands highly within a single region, giving rise to either core-embedded or policy-anchored spatial layouts. In contrast, Beijing’s gentle gradient implies that innovation demands are distributed across multiple points, which inherently requires networked and specialized pilot-scale nodes to serve different functional poles. This creates an intrinsic need for a “networked and collaborative” layout pattern. This difference in demand distribution patterns is closely related to the gradient characteristics of leading enterprise agglomeration in the three cities: Wuhan exhibits the highest concentration of leading enterprises (72.8%), with highly polarized demand; Shanghai follows (65.9%), with demand concentrated in a single core; Beijing has the lowest concentration (47.2%), with demand exhibiting a multi-polar distribution. This gradient is consistent with the expectation of Hypothesis H2 regarding the higher degree of spatial agglomeration in policy-driven regions, thereby supporting this hypothesis.

4. Multi-Case Comparison and Typological Refinement of Pilot-Scale Base Construction Models

4.1. Cross-Case Comparison: A Spectrum of Differences in the Spatial Organization Logic of Pilot-Scale Bases in the Three Cities

The comparative analysis of the three cities reveals a systematic spectrum of differences (Table 7). These differences result from the combined effects of regional resource endowments, market mechanisms, and development strategies, which profoundly influence the functional roles of the pilot-scale bases.
Corresponding patterns to these differences can also be identified in other regions of China. For instance, the Guangdong-Hong Kong-Macao Greater Bay Area may exhibit more complex polycentric network and market-driven characteristics, while the Chengdu-Chongqing economic circle might demonstrate a unique “dual-core interaction” mode. The typological framework from this study provides a preliminary analytical lens for understanding the layout logic of pilot-scale bases in these regions.
Beijing’s polycentric network structure is a complex adaptive system. It evolved over the long term through the combined forces of self-organization and planning interventions, guided by market-oriented reforms and spatial strategy, and built upon a substantial knowledge stock. Its innovation ecosystem emphasizes functional complementarity and connection efficiency among nodes. Shanghai’s unipolar radial structure originates from the initial shaping by national strategy and the continued reinforcement of global market forces. The coupling of these two factors produces a powerful “agglomeration-radiation” effect, forming a polarized subsystem deeply embedded in the global innovation network. Its innovation ecosystem emphasizes the high capacity level and global competitiveness of its core. Wuhan’s policy-guided single-core agglomeration structure is the outcome of a government-led strategic coupling. Under conditions of a weak industrial foundation, this approach forcibly connects local educational and scientific resources with external industrial capital within a specific space (the Optics Valley Biolake). Its innovation ecosystem emphasizes the cultivation and generative capacity of the core platform.
The aforementioned patterns are also reflected in other regions of China. For instance, the Guangdong-Hong Kong-Macao Greater Bay Area may exhibit more complex polycentric network and market-driven characteristics, while the Chengdu-Chongqing Economic Circle may demonstrate a distinctive “dual-core interaction” model. Based on observations from the three case cities, these differences can be preliminarily summarized into three spatial organization logics, which exhibit gradient differences in spatial structure, driving forces, evolutionary paths, and the distribution of leading enterprises, forming a rudimentary continuum spectrum ranging from mature innovation ecosystems to policy-driven clusters. It should be noted that this spectrum classification is primarily based on comparative observations from the three case cities, and its complete form and intermediate types require supplementation and validation through additional city samples.

4.2. Differentiated Spatial Organization Logic of Pilot-Scale Bases

Within China’s urban system, Beijing and Shanghai both belong to the top national tier of capacity. Among them, Beijing serves as the political center, while Shanghai functions as a global resource-allocation hub characterized by an open model of “market-led, government-enabled” development. Wuhan operates as a central city in the central region, following a “government-guided marketization” path.
The spatial organization of shared pilot-scale bases in the three cities demonstrates a logic of “common anchors, differentiated adaptation”. The commonality lies in their layouts being anchored in regions of high innovation concentration-that is, areas with a dense concentration of innovation elements formed by the high agglomeration of leading enterprises, advanced R&D institutions, and specialized service providers. Differences stem from variations in the types and proportional composition of innovation elements: Beijing leverages a dual-driven model of knowledge and policy, where its pilot-scale bases act as network synergy hubs. They adopt a polycentric form to serve northern R&D sourcing and southern industrial transformation, promoting functional complementarity. Driven by market forces and globalization, Shanghai’s pilot-scale bases primarily function as core function enhancers. They are highly concentrated in Pudong to support cutting-edge, highly complex R&D verification, thereby strengthening its unipolar competitiveness. In Wuhan, pilot-scale bases, under the mutual reinforcement of policy and market forces, rapidly steer industrial agglomeration.
This differentiated spatial organization further catalyzes the formation of localized pathways for “fostering industrial aggregation through pilot-scale activities”, mediated by the pivotal role of leading enterprises. This process transforms the static service capacity of pilot-scale facilities into a dynamic capability for cultivating industrial clusters. Strategically siting pilot-scale bases around leading enterprises enables efficient alignment with their urgent and high-standard pilot-scale demands. Through the leading enterprises’ capabilities in technology spillover, supply-chain integration, and spin-off incubation, this approach rapidly attracts upstream and downstream supporting firms and additional innovation elements to further agglomerate spatially. Therefore, the effectiveness of a pilot-scale base depends not only on its locational coupling with high-concentration areas but, more critically, on its precise embedding within and service to the innovation network led by leading enterprises. This enables a functional leap from passively responding to demand to actively shaping the ecosystem.

4.3. Typological Refinement of Construction Models for Pilot-Scale Bases

Based on the above mechanism analysis, this study refines three fundamental models for constructing biomedical pilot-scale bases, grounded in the spatial organization of innovation actors (Table 8). These three models correspond respectively to the spatial structure characteristics exhibited by the case cities of Beijing, Shanghai, and Wuhan: Beijing’s polycentric network structure corresponds to the Network Synergy Type; Shanghai’s unipolar radial structure corresponds to the Core-Embedded Type; Wuhan’s single-core agglomeration structure corresponds to the Policy-Anchored Type.
The comparative analysis of the three case cities suggests that the effectiveness of pilot-scale bases may be closely related to the “structure-dynamics-capacity” configuration of their respective innovation ecosystems. Under the Network Synergy Type, pilot-scale bases need to strengthen functional connections among multiple nodes; under the Core-Embedded Type, pilot-scale bases must focus on precise services targeting high-level demands; under the Policy-Anchored Type, pilot-scale bases are required to play an agglomerative role as fundamental public platforms. This correlational pattern can be regarded as a theoretical hypothesis warranting further validation: namely, that the efficacy of a pilot-scale base depends on the degree of deep alignment with the structure of the local innovation ecosystem.
It must be emphasized that the three models outlined above are not “best practices” to be arbitrarily applied; rather, they are products deeply aligned with their respective contexts: Beijing’s dual-drive background of knowledge and policy, Shanghai’s market and globalization background, and Wuhan’s strong policy planning background. The effectiveness of any given model is highly dependent on the resource endowment, developmental stage, and institutional environment of its host city. For instance, the Policy-Anchored Type successfully achieved rapid agglomeration in Wuhan; however, were it to be replicated in Shanghai, it might conflict with the mature market mechanisms in place. Conversely, the Core-Embedded Type has strengthened Shanghai’s global competitiveness, but in Wuhan, it might be unsustainable due to the lack of sufficient high-level demand. Therefore, the primary task in planning and constructing a pilot-scale base is to accurately diagnose the “structure-dynamics-capacity” configuration of the local innovation ecosystem, and subsequently select a model that is compatible with it.

5. Discussion

Building on the clarification of the correspondence between the core findings and spatial evidence, this section conducts an in-depth discussion focusing on the causal mechanism of “fostering industrial aggregation through pilot-scale activities” and practical issues in spatial organization, while also identifying the limitations of this study and directions for future research.

5.1. Spatial Evidence Supporting the Core Findings

Spatial analysis based on POI data provides direct evidence supporting the following conclusions:
(1) Spatial structure morphology. Kernel density analysis (Figure 2, Figure 4 and Figure 6) directly presents the differentiated spatial structures of the three cities: Beijing’s polycentric network, Shanghai’s unipolar radial pattern, and Wuhan’s single-core agglomeration. Category-specific analysis (Figure 3, Figure 5 and Figure 7) further reveals functional differentiation patterns: “R&D in the north, industrialization in the south” in Beijing; “Pudong leading, multi-district collaboration” in Shanghai; and “single-core integration” in Wuhan.
(2) Anchor characteristics of pilot-scale bases. Point overlay analysis shows that pilot-scale bases in all three cities are located within or adjacent to high-value areas of enterprise density (annotated in Figure 2, Figure 4 and Figure 6), directly supporting the conclusion that “shared pilot-scale bases anchor themselves in regions of high innovation concentration”.
(3) Co-agglomeration characteristics with leading enterprises. Overlay analysis of leading enterprise points (Figure 9) and pilot-scale bases indicates that leading enterprises in all three cities are highly concentrated in the core areas where pilot-scale bases are located, providing direct evidence for the spatial strategy observation of “strategic placement around leading enterprises”.
(4) Differences in evolutionary paths. Phased kernel density analysis (Figure 8) directly presents the evolutionary trajectories of the three cities: Beijing’s “peripheral incubation—center polarization—network synergy”; Shanghai’s “unipolar initiation—multi-district diffusion—functional integration”; and Wuhan’s “dispersed germination—policy-driven—structural lock-in”.
Building on this direct evidence, this study further derives a theoretical explanation regarding the mechanism of “fostering industrial aggregation through pilot-scale activities”, which is discussed in the following sections.

5.2. Innovation—High-Concentration Regions as Anchors and the “Fostering Industrial Aggregation Through Pilot-Scale Activities” Mechanism Led by Leading Enterprises

Existing research emphasizes that the location selection of key infrastructure is closely related to the spatial form and industrial resilience of local industrial clusters [41,42]. The primary empirical finding of this study supports this view: shared pilot-scale bases commonly use regions with a high concentration of innovation elements as their spatial anchor. This choice stems from the pursuit of knowledge spillovers, talent mobility, supply-chain synergy, and rapid iteration efficiency [45].
However, establishing an anchor point is only the starting point for spatial layout. A question of greater theoretical and practical significance is: after the anchor point forms, how can effective spatial and organizational strategies promote its continuous evolution and ultimately drive the upgrade and development of the industrial cluster?
Spatiotemporal evolution and capacity gradient analysis in this study reveal a high degree of spatial overlap between leading enterprises and pilot-scale bases, with leading enterprise agglomeration areas often serving as the core growth poles of innovation activities. This finding supports the following theoretical inference: strategic placement around leading enterprises may generate “radiation-attraction” effects through the output of technical standards, supply chain integration, spin-off enterprise incubation, and high-end talent mobility. These effects drive the further spatial agglomeration of upstream and downstream supporting firms, R&D institutions, and service platforms, thereby forming localized innovation clusters with pilot-scale bases as hubs and leading enterprises as growth poles. This process essentially transforms the “static service capacity” of pilot-scale facilities into a “dynamic ecosystem-building capacity”, confirming that high-level agglomeration economies derive not only from infrastructure sharing but also from endogenous growth drivers catalyzed by knowledge spillovers and talent mobility.
It should be noted that the aforementioned mechanism implies a clear hypothesis regarding causal direction: that pilot-scale bases are sited around leading enterprises to serve their needs. However, the phenomenon of spatial co-agglomeration itself may be subject to multiple competing explanations: (1) The demand-driven hypothesis: The process scale-up demands of leading enterprises attract pilot-scale bases to locate nearby; (2) The facility-driven hypothesis: Pilot-scale bases, as public platforms, attract leading enterprises and supporting firms to agglomerate around them; (3) The co-determination hypothesis: A third factor attracts both simultaneously. Distinguishing between these hypotheses requires tracing the temporal matching relationship between the establishment dates of pilot-scale bases and the registration dates of enterprises. The three case cities provide preliminary evidence for testing these hypotheses. The planning of Wuhan Optics Valley Biolake commenced in 2008, and the registration proportions of enterprises in Wuhan during 2009–2016 and 2017–2024 reached 28.61% and 55.31%, respectively, far exceeding the 16.07% during the industry germination period. This indicates accelerated enterprise agglomeration following the establishment of the science park, providing support for the facility-driven hypothesis. Shanghai Zhangjiang Pharmaceutical Valley has been under development since the 1990s, with the Pudong New Area becoming a dense core during the 2000–2008 germination period, subsequently diffusing to multiple districts. This exhibits a “core initiation—market diffusion” characteristic, more closely aligning with a hybrid model where demand-driven and facility-driven effects are superimposed. Beijing Zhongguancun Life Science Park (established in 2000) is located in the knowledge-intensive northern region; however, the R&D cluster in the north did not significantly intensify until 2009–2016. The industrialization demands predating the park’s establishment likely originated from knowledge spillovers, with platform services following in the later stage, reflecting a temporal sequence where knowledge sources drive development first, and pilot-scale platforms embed themselves subsequently.
Taken together, the three case cities demonstrate that causal pathways vary according to urban developmental stages and dominant driving forces: latecomer catch-up cities are more likely to exhibit a facility-driven model characterized by “platforms established first, enterprises following later”; mature market-oriented cities display bidirectional reinforcement features; and knowledge-originating cities tend to follow a demand-driven model characterized by “spontaneous enterprise agglomeration occurring first, with platform services embedding subsequently”. This finding reveals that the specific implementation pathways of the mechanism for “fostering industrial aggregation through pilot-scale activities” exhibit urban heterogeneity.
The validation of H1–H3 above further reveals an important trade-off: policy intervention can accelerate industrial agglomeration but may entail the risk of path dependence; market-driven evolution proceeds more slowly but tends to generate more resilient spatial configurations. This trade-off holds significant implications for the planning of pilot-scale bases: site selection should not stop at high-concentration areas; rather, it requires proactively identifying and embedding into local innovation networks led by leading enterprises, strengthening synergistic relationships, thereby activating and amplifying the cluster-catalyzing effect of “fostering industrial aggregation through pilot-scale activities”.

5.3. Problems in Spatial Organization

Constrained by limited land resources, historically solidified spatial structures, and the self-adjustment induced by high costs in mature markets, Beijing and Shanghai exhibit a spatial trend toward networked and polycentric collaboration in their innovation functions. Consequently, their morphological agglomeration intensity is lower than that of Wuhan. In contrast, as a latecomer city pursuing catch-up development, Wuhan leveraged strong government planning, concentrated land supply, and the anchoring role of strategic platforms during its critical development period. This enabled it to form a highly agglomerated, single-core-dominated spatial morphology within a relatively short timeframe.
Urban heterogeneity also shapes the evolutionary paths of innovation networks, thereby imposing different requirements on the planning timeline and spatial flexibility of pilot-scale bases. The innovation network evolution in Beijing and Shanghai is relatively gradual, with long-term synergy among market forces, knowledge, and policy, resulting in a resilient structure. Therefore, the planning of their pilot-scale bases should emphasize modular design, functional scalability, and multi-actor collaboration to accommodate future industrial restructuring and the emergence of new growth poles.
In contrast, Wuhan’s evolutionary path displays distinct policy-driven and rapid structurization characteristics. Its pilot-scale bases need to align closely with the construction of core policy platforms, adopting a project-based advancement approach. This ensures the timely provision of production capacity and technical support during critical windows, thereby reinforcing the initial agglomeration momentum. Furthermore, proactive planning for functional upgrades in later stages is essential to avoid path dependency.

5.4. Research Limitations and Future Outlook

This study has several limitations that should be considered when interpreting the conclusions.
First, the issue of “survival bias” in the temporal evolution analysis. The temporal evolution analysis divides the study period into three phases (2000–2008, 2009–2016, and 2017–2024) based on enterprise registration dates to reconstruct the spatial dynamics of the industry. Although this method effectively captures the spatiotemporal characteristics of enterprise entry and initial spatial distribution, it has an inherent limitation: it only captures surviving enterprises and cannot reflect dynamic processes such as enterprise closures, relocations, or mergers and acquisitions. Consequently, the evolutionary landscape presented in Figure 8 may suffer from “survival bias”, meaning it systematically biases towards more successful or stable enterprises while insufficiently capturing the process of “creative destruction” within industrial spatial dynamics. This bias may, to some extent, overestimate the stability of existing agglomeration areas. For example, if enterprise closures and relocations were taken into account, the actual agglomeration intensity of the single-core pattern in Wuhan’s Optics Valley Biolake might be lower than the level suggested by survival data. Similarly, in the polycentric networks of Beijing and Shanghai, there may be secondary nodes whose evolution has been overlooked due to enterprise relocations. Future research should integrate multi-source data such as official cancellation records and spatial relocation trajectories, adopting longitudinal tracking methods to more comprehensively reveal the true picture of industrial spatial evolution from the perspective of the full enterprise lifecycle—namely, “entry, exit, and relocation”.
Second, the absence of relational dimension data. This study primarily relies on POI data to reveal the spatial patterns of innovation actors. While effectively capturing distribution and agglomeration characteristics, it remains insufficient in capturing relational dimensions such as collaboration networks and knowledge flow intensity among actors. Future research could integrate multi-source data, including patent cooperation, supply chains, and talent mobility, to further elucidate the interaction mechanisms between “spatial proximity” and “relational proximity” in pilot-scale collaboration.
Third, the limitation of the case selection scope. This study focuses on three typical cities—Beijing, Shanghai, and Wuhan—which cover the knowledge-driven, market-driven, and policy-driven development paradigms. However, it does not encompass regions with greater synergy and complexity, such as the Guangdong-Hong Kong-Macao Greater Bay Area or the Chengdu-Chongqing region. Future research could extend the case studies to these regions to test and enrich the typological spectrum proposed in this paper. Furthermore, the relationship between the governance structure and operational models of pilot-scale bases and their spatial performance has not been thoroughly explored. Subsequent research could combine in-depth case descriptions with performance evaluation to provide more actionable policy insights for enhancing the service capacity and sustainability of pilot-scale platforms.

6. Conclusions

In view of the heterogeneous characteristics of China’s biomedical innovation ecosystem, this study constructs a multi-dimensional classification framework for innovation actors based on their functions in the pilot-scale process. Through a cross-case spatial analysis of Beijing, Shanghai, and Wuhan, it reveals the spatial organization logic and typological characteristics of shared pilot-scale bases. The main conclusions are as follows:
First, employing typological theory and methods, this study refines the generalized concept of “innovation actors” within regional innovation systems into five functional communities, providing a foundation for the precise analysis of the spatial structure of innovation ecosystems. Second, through cross-case comparison, it reveals the diverse and adaptive implementation pathways of the mechanism for “fostering industrial aggregation through pilot-scale activities”. In contrast to the single model dominated by market economies in the West, the three Chinese case cities demonstrate diversified pathways for innovation infrastructure construction shaped by the heterogeneity of urban industrial clusters. This not only complements Western theoretical perspectives but also offers a new theoretical reference for innovation infrastructure construction in countries with transitional economies, deepening the theoretical understanding of the interactive relationship between innovation infrastructure and industrial clusters.
Second, the effectiveness of shared pilot-scale bases depends not only on their location within spatial anchors characterized by high concentrations of innovation elements but, more critically, on their spatial synergistic relationships with core functional actors within the local ecosystem. It should be noted that the aforementioned mechanism implies a clear hypothesis regarding causal direction: that pilot-scale bases are sited around leading enterprises to serve their needs. However, the phenomenon of spatial co-agglomeration itself may be subject to multiple competing explanations: the high-standard demands of leading enterprises guide pilot-scale services to locate nearby, while the public technical service capacity of pilot-scale platforms may also attract further enterprise agglomeration. If this inference holds, pilot-scale facilities have the potential to transform from passive service platforms into active incubators of industrial clusters, thereby driving a virtuous cycle of “fostering industrial aggregation through pilot-scale activities”. However, it must be emphasized that this mechanism still requires validation through longitudinal data and causal identification methods in future research”.
Finally, heterogeneity in economic foundations, resource endowments, and policy orientations across cities leads to systematic differentiation in the function and morphology of innovation networks. This necessitates that the construction of pilot-scale bases must move beyond generic models and instead adapt to the unique structure of the local regional innovation ecosystem.
This study not only provides a new theoretical perspective and practical basis for spatial policymaking in China’s biomedical industry but also offers a methodological framework with referential value for other innovation ecosystems characterized by significant heterogeneity.

Author Contributions

Conceptualization, F.C. and M.G.; methodology, F.C. and M.G.; software, M.G.; data curation, M.G.; writing—original draft preparation, M.G.; writing—review and editing, M.G. and F.C.; visualization, M.G.; funding acquisition, F.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Innovation Capability Support Program of Shaanxi, grant number 2025KG-YBXM-115, and the Innovation Capability Support Program of Xianyang City, grant number L2024-CXNL-RKX-0011. The APC was funded by the aforementioned funds.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

We sincerely acknowledge the financial support for this research from the Innovation Capability Support Program of Shaanxi and the Innovation Capability Support Program of Xianyang City.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
POIPoint of Interest
KDEKernel Density Estimation

References

  1. Liu, X.; Zhang, G. Innovation ecosystem: Exploring the essence and paradigm shift of innovation-driven development. Sci. Technol. Prog. Policy 2016, 33, 1–6. (In Chinese) [Google Scholar] [CrossRef]
  2. Yin, X.; Chen, F.; Chen, L. Research on the construction path of pilot-scale verification platforms under the “technology-organization-scenario” framework: A case study of the Guangdong-Hong Kong-Macao Greater Bay Area Industrial Internet Public Technology Service Platform. Sci. Sci. Manag. S.&T. 2024; in press. (In Chinese)
  3. Xu, Q. Phased and systematic proof-of-concept is the “key link” for the transformation of scientific and technological achievements. China Soft Sci. 2024, 3, 174–178. (In Chinese) [Google Scholar]
  4. Zhou, Y.; Zhang, X.; Zhao, F.; Wang, F. How do Public Demonstration Projects Promote Green-Manufacturing Technologies? A Case Study from China. Sustain. Dev. 2015, 23, 217–231. [Google Scholar] [CrossRef]
  5. Chaudhuri, A. Simultaneous improvement in development time, cost and quality: A practical framework for generic pharmaceuticals industry. R&D Manag. 2013, 43, 227–241. [Google Scholar] [CrossRef]
  6. Wang, G.; Wang, R.; Xu, H. Research on the Construction Path and Strategy of Pilot-Scale Platforms in the Digital-Intelligence Era: A Synergistic Perspective Based on International Experience and Domestic Practice. Sci. Res. Manag. 2025, 43, 63–69. (In Chinese) [Google Scholar] [CrossRef]
  7. Markham, S.K.; Ward, S.J.; Aiman-Smith, L.; Kingon, A.I. The Valley of Death as Context for Role Theory in Product Innovation. J. Prod. Innov. Manag. 2010, 27, 402–417. [Google Scholar] [CrossRef]
  8. Beard, T.R.; Ford, G.S.; Koutsky, T.M.; Spiwak, L.J. A Valley of Death in the innovation sequence: An economic investigation. Res. Eval. 2009, 18, 343–356. [Google Scholar] [CrossRef]
  9. Hou, X.; Li, T. Quantitative Analysis of Policy Texts on Pilot-Scale Bases in China. Technol. Econ. Guide 2025, 33, 47–63. (In Chinese) [Google Scholar]
  10. Frishammar, J.; Richtnér, A.; Brattström, A.; Magnusson, M.; Björk, J. The role of pilot and demonstration plants in technological development: Synthesis and directions for future research. Technol. Anal. Strateg. Manag. 2015, 27, 1–18. [Google Scholar] [CrossRef]
  11. Chen, Y. Exploring the path of pilot-scale development: Grasping four key links and managing four-dimensional relationship models. State-Owned Assets Manag. 2025, 1, 20–25. (In Chinese) [Google Scholar]
  12. Tang, Y.; Motohashi, K.; Hu, X.; Montoro-Sanchez, A. University-industry interaction and product innovation performance of Guangdong manufacturing firms: The roles of regional proximity and research quality of universities. J. Technol. Transfer 2020, 45, 578–618. [Google Scholar] [CrossRef]
  13. Berchicci, L. Towards an open R&D system: Internal R&D investment, external knowledge acquisition and innovative performance. Res. Policy 2013, 42, 117–127. [Google Scholar] [CrossRef]
  14. Xu, L.; Yu, H.; Wang, Z.; Wang, C.; Liu, Q. High-Quality Development of China’s Biopharmaceutical Industry: Current Status, Problems, and Countermeasures. Eng. Sci. 2025, 27, 92–105. (In Chinese) [Google Scholar] [CrossRef]
  15. Lyu, Y.; Zhu, Y.; Han, S.; He, X.; Lin, H. Open innovation and innovation “Radicalness”—The moderating effect of network embeddedness. Technol. Soc. 2020, 62, 101389. [Google Scholar] [CrossRef]
  16. Zhu, L.; Wang, C.; Fan, Y. Analysis on the Current Situation, Bottlenecks and Optimization Paths of Pilot-Scale Maturation Platform Construction in Chengdu. Decis.-Mak. Consult. 2025, 4, 62–65. (In Chinese) [Google Scholar]
  17. Qiu, C. Transformation Strategy of Scientific and Technological Achievements Based on Pilot-Scale Resource Sharing. China Dev. Obs. 2015, 9, 54–55. (In Chinese) [Google Scholar]
  18. Liu, Z. Paths and Practices of Urban Renewal in Industrial Zones with Shortage of Innovation Elements. Planners 2023, 39, 128–132. (In Chinese) [Google Scholar]
  19. Li, S.; Shao, F. Obstacles to Knowledge Flow in Regional Innovation Systems and Their Resolution. Chin. J. Manag. 2006, 3, 109–112. (In Chinese) [Google Scholar]
  20. Adams, J.D. Comparative localization of academic and industrial spillovers. J. Econ. Geogr. 2002, 2, 253–278. [Google Scholar] [CrossRef]
  21. Russell, M.G.; Smorodinskaya, N.V. Leveraging complexity for ecosystemic innovation. Technol. Forecast. Soc. Change 2017, 136, 114–131. [Google Scholar] [CrossRef]
  22. Ron, A. Match your innovation strategy to your innovation ecosystem. Harv. Bus. Rev. 2006, 84, 98–107+148. [Google Scholar]
  23. Wang, X. Research on the Configuration of Scientific and Technological Achievement Transformation in High-Tech Industries under the TOE Framework. Sci. Res. Manag. 2024, 45, 164–173. (In Chinese) [Google Scholar] [CrossRef]
  24. Guan, M.; Sun, S. Agglomeration Characteristics and Influencing Factors of Urban Innovation Space: A Case Study of Nanjing Main City. City Plan. Rev. 2023, 47, 21–31. (In Chinese) [Google Scholar] [CrossRef]
  25. Chen, F.; Fan, J. Internet Platform Empowers New Quality Productive Forces: How and with What to Empower. Southwest Financ. 2024, 9, 89–100. (In Chinese) [Google Scholar]
  26. Hutton, T.A. The New Economy of the inner city. Cities 2004, 21, 89–108. [Google Scholar] [CrossRef]
  27. Deng, Z.; Tu, Q. New Trends and Determinants of Spatial Location Choice of Innovative Enterprises in Metropolitan Areas: An Empirical Study Based on US Metropolitan Areas. World Econ. Stud. 2014, 9, 10–15. (In Chinese) [Google Scholar] [CrossRef]
  28. Wang, B.; Xie, J.; Wang, L. The Impact of Intra-Urban Innovation Space Agglomeration Evolution and Environmental Factors on Innovation Output: A Case Study of Shenzhen. Econ. Geogr. 2024, 44, 84–90. (In Chinese) [Google Scholar] [CrossRef]
  29. Sun, W.; Wu, D.; Peng, Z. Transportation Accessibility, Economic Linkage and Urban Centrality in the Yangtze River Delta. J. Qingdao Univ. (Nat. Sci. Ed.), 2024; in press. (In Chinese)
  30. Cao, Z.; Derudder, B.; Peng, Z.W. Interaction between different forms of proximity in inter-organizational scientific collaboration: The case of medical sciences research network in the Yangtze River Delta region. Pap. Reg. Sci. 2019, 98, 1903–1924. [Google Scholar] [CrossRef]
  31. Cao, Z.; Chen, H.; Qiu, W.; Zhang, H. The Impact of Multidimensional Proximity on the Formation of Regional Innovation Collaboration Networks: An Empirical Study of Medical Research Institutions in Jiangsu, Zhejiang and Shanghai. Geogr. Res. 2022, 41, 2531–2547. (In Chinese) [Google Scholar] [CrossRef]
  32. Yuan, Q.; Li, G.; Xue, Y. Science and Innovation Transformation and Spatial Response of Guangzhou Development Zone from the Perspective of Industrial Clusters. Urban Plan. Forum 2022, 4, 95–102. (In Chinese) [Google Scholar] [CrossRef]
  33. Tao, H.; Tian, J.; Liu, J. Analysis of the Path for Quality Infrastructure and Digitalization to Synergistically Drive Industrial Chain Quality Improvement: A Case Study of a Regional New Display Industry. China Stand. 2025, 19, 282–286. (In Chinese) [Google Scholar] [CrossRef]
  34. Yan, J.; Zhu, L.; Qi, N. Regional Innovation Ecosystem: Theoretical Framework and Research Prospects. Technol. Innov. Manag. 2022, 43, 620–631. (In Chinese) [Google Scholar] [CrossRef]
  35. Wu, L.; Chen, L.; Song, G. Analysis of the Development Status of Domestic and International Bio-Industry and Parks. East China Sci. Technol. 2016, 10, 44–49. (In Chinese) [Google Scholar]
  36. Zhang, W.; Zhao, J. Exploring a Contemporary Planning and Design Method for Biomedical Laboratory Parks. World Archit. 2023, 2, 24–33. (In Chinese) [Google Scholar] [CrossRef]
  37. Cheng, F.; Yang, B.; Fan, H. Innovation in Land Resource Element Allocation from the Perspective of New Quality Productive Forces: A Case Study of Shanghai’s Biomedical Industry. Urban Plan. Forum 2025, 4, 72–79. (In Chinese) [Google Scholar] [CrossRef]
  38. Zhang, S.R.; Hu, T.Y.; Zhang, T.Y.; Ju, H.R.; Wang, Y.J. Tourism Development of Cultural Heritage Resources Through Conservation Concepts: A Case Study of Ningxia, China. Land 2025, 14, 201. [Google Scholar] [CrossRef]
  39. Tang, X.X.; Zou, C.; Shu, C.; Zhang, M.Q.; Feng, H.C. Research on Site Selection Planning of Urban Parks Based on POI and Machine Learning—Taking Guangzhou City as an Example. Land 2024, 13, 1362. [Google Scholar] [CrossRef]
  40. Chen, Y.H.; Li, R. Spatial Distribution and Type Division of Traditional Villages in Zhejiang Province. Sustainability 2024, 16, 5262. [Google Scholar] [CrossRef]
  41. García-Granero, E.M.; Piedra-Muñoz, L.; Galdeano-Gómez, E. Measuring eco-innovation dimensions: The role of environmental corporate culture and commercial orientation. Res. Policy 2020, 49, 104028. [Google Scholar] [CrossRef]
  42. Zhang, Y.H.; Wang, Z.; Peng, Y.R.; Wang, W.; Tian, C.X. Spatial-Temporal Evolution and Influencing Mechanism of Coupling Coordination Level of Social-Ecological Systems in China’s Resource-Based Cities Under the Carbon Neutrality Goal. Land 2025, 14, 207. [Google Scholar] [CrossRef]
  43. Jiménez, F.B.G.; Corredera, S.R. Spatial Analysis Model for the Evaluation of the Territorial Adequacy of the Urban Process in Coastal Areas. Land 2024, 13, 109. [Google Scholar] [CrossRef]
  44. Su, Y.T.; Li, J.; Yin, S.Q.; Yue, J.B.; Jiang, Z.; Ma, T.Y.; Han, Z.Q. Spatial and Temporal Variation Characteristics and Driving Mechanisms of Multidimensional Socio-Economic Development Levels in Resource-Based Cities. Sustainability 2023, 15, 1573. [Google Scholar] [CrossRef]
  45. Zhang, K.H.; Qian, Q.L.; Zhao, Y.J. Evolution of Guangzhou Biomedical Industry Innovation Network Structure and Its Proximity Mechanism. Sustainability 2020, 12, 2456. [Google Scholar] [CrossRef]
Figure 1. Study Area.
Figure 1. Study Area.
Urbansci 10 00234 g001
Figure 2. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Beijing.
Figure 2. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Beijing.
Urbansci 10 00234 g002
Figure 3. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Beijing. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Figure 3. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Beijing. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Urbansci 10 00234 g003
Figure 4. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Shanghai.
Figure 4. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Shanghai.
Urbansci 10 00234 g004
Figure 5. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Shanghai. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Figure 5. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Shanghai. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Urbansci 10 00234 g005
Figure 6. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Wuhan.
Figure 6. Spatial Agglomeration Analysis of Biomedical Enterprises and Higher Education Institutions in Wuhan.
Urbansci 10 00234 g006
Figure 7. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Wuhan. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Figure 7. Spatial Agglomeration Analysis of Various Categories of Biomedical Enterprises in Wuhan. (a) R&D-driven enterprises; (b) Platform and service-oriented enterprises; (c) Core tools and material suppliers; (d) Medical device and diagnostic equipment enterprises; (e) Pharmaceutical circulation service-oriented enterprises; (f) Quantitative analysis of enterprise types.
Urbansci 10 00234 g007
Figure 8. Temporal Evolution Analysis Map of Biomedical Enterprises in the Three Cities. (a) Beijing; (b) Shanghai; (c) Wuhan.
Figure 8. Temporal Evolution Analysis Map of Biomedical Enterprises in the Three Cities. (a) Beijing; (b) Shanghai; (c) Wuhan.
Urbansci 10 00234 g008
Figure 9. Capacity Gradient Analysis Map of Biomedical Enterprises in the Three Cities. (a) Beijing; (b) Shanghai; (c) Wuhan.
Figure 9. Capacity Gradient Analysis Map of Biomedical Enterprises in the Three Cities. (a) Beijing; (b) Shanghai; (c) Wuhan.
Urbansci 10 00234 g009
Table 1. A Review of Core Theories and Empirical Studies.
Table 1. A Review of Core Theories and Empirical Studies.
Theoretical
Perspective
Key Research FindingsCase City Characteristics: A Preview
BeijingShanghaiWuhan
Industrial Cluster & Innovation Ecosystem TheoryInnovation relies on knowledge spillovers, actor synergy, and resource sharingPolycentric network synergy: R&D in the north, industrialization in the south, platform services embedded in dual coresUnipolar radiation with functional complementarity: Pudong as the leading core, specialized collaboration across multiple districtsSingle-core agglomeration and functional integration: Optics Valley Biolake concentrates >70% of firms, with underdeveloped supporting sectors
Multi-Dimensional Proximity TheoryGeographic, cognitive, institutional, and social proximities jointly influence innovation collaborationMulti-dimensional proximity synergy: geographic + cognitive proximity between R&D and universities; geographic +institutional proximity embedded in platform servicesGeographic + institutional dual drive: R&D highly concentrated in Zhangjiang; policy-guided functional linkagesPolicy-mandated forced proximity: Strong geographic proximity, lagging cognitive and institutional proximity
Institutional Thickness TheoryRegional development depends on the interaction between the institutional environment and firm agglomerationKnowledge + policy dual drive: Synergy between policy decentralization and knowledge spilloversStrategy + market strong coupling: National strategy shapes initial pattern, market forces continuously reinforce the unipolar corePolicy-anchored: Strategic planning enables rapid agglomeration, institutional thickness dependent on policy supply
Table 2. Multidimensional Classification of “Entity Functions-Pilot-Scale Linkage” for Core Populations in the Biomedical Industry.
Table 2. Multidimensional Classification of “Entity Functions-Pilot-Scale Linkage” for Core Populations in the Biomedical Industry.
Core PopulationRepresentative OrganizationsFunctional Orientation in the Pilot-Scale Process
Higher Education InstitutionsResearch universities
(with strengths in life sciences, medicine, pharmacy)
Knowledge source and principle verification:
Engage in cutting-edge basic research, generating initial pilot-scale demands.
Research InstitutesNational/provincial-level key laboratories,
Engineering research centers
Technology incubation and collaborative R&D:
Focus on application-oriented R&D, bridging basic research and enterprise pilot-scale activities.
EnterprisesPlatform and service-orientedPilot-scale efficacy verification:
Provide technical services from preclinical to clinical research, supporting clinical trial applications.
Core tools and material suppliersPilot-scale material support:
Supply key materials, equipment, and technologies, influencing process stability.
R&D-driven enterprisesPilot-scale demand initiation:
Translate scientific discoveries into R&D projects; primary clients of CDMOs. (Innovative Biotech)
Independent pilot-scale leadership:
Possess a complete in-house pilot-scale system; core objectives are process finalization and cost control.
(Traditional/Integrated pharmaceutical companies)
Pharmaceutical circulation service-orientedCommercialization undertaking:
Responsible for drug distribution and logistics, with no direct linkage to pilot-scale activities.
Medical devices and diagnostic equipmentIndependent device pilot-scale:
Follow medical device GMP standards; complete the transformation from prototype to sample and clinical adaptation verification.
Table 3. Statistics of Biomedical Enterprise POI Data in the Three Cities.
Table 3. Statistics of Biomedical Enterprise POI Data in the Three Cities.
CityTotal Number of EnterprisesR&D-DrivenPlatform and Service-OrientedCore Tools and Material SuppliersMedical Devices and Diagnostic EquipmentPharmaceutical Circulation Service-Oriented
Beijing1923 1471191205467689
Shanghai2528996196310803485
Wuhan9922135893212416
1 If the same enterprise falls into multiple categories, it is counted repeatedly in each relevant category’s total but is not counted repeatedly in the overall enterprise count.
Table 4. Comparative Analysis of Spatial Distribution Patterns of Biomedical Enterprises in the Three Cities.
Table 4. Comparative Analysis of Spatial Distribution Patterns of Biomedical Enterprises in the Three Cities.
CitySpatial Structure PatternCore Agglomeration AreaSpatial Differentiation CharacteristicsDominant Driving Forces
BeijingPolycentric, networked structureNorthern region (Haidian District, Changping District)
Southern region
(Daxing District)
R&D in the north, industrialization in the south, embedded services, spatially separated marketsKnowledge and policy co-driven
ShanghaiSingle-pole leadership with multi-district collaborationPudong New Area (Zhangjiang Science City)Pudong-led, multi-district collaboration, market-drivenMarket and globalization driven
WuhanSingle-core, axial expansionOptics Valley BiolakeSingle-core agglomeration with axial extensionStrong policy planning driven
Table 5. Comparison of Spatiotemporal Evolution Characteristics of Biomedical Enterprises in the Three Cities.
Table 5. Comparison of Spatiotemporal Evolution Characteristics of Biomedical Enterprises in the Three Cities.
CityProportion of Registered Enterprises in Each Development Stage (%)Evolution Path PatternCore Driving Forces
Industry Germination Period
(2000–2008)
Rapid Expansion Period
(2009–2016)
Innovation and High-Quality Development Period (2017–2024)
Beijing24.3834.7240.89Peripheral Incubation-Center Polarization-Network SynergySynergistic Drive of Planning Guidance and Knowledge Spillover
Shanghai20.5347.3832.08Unipolar Initiation-Multipolar Expansion-Region-Wide SynergyStrong Coupling of National Strategy and Market Mechanisms
Wuhan16.0728.6155.31Dispersed Germination-Policy-Driven-Structural Lock-inStrong Policy Intervention and Targeted Resource Allocation
Table 6. Spatial Distribution and Capacity Gradient Statistics of Leading Enterprises in the Three Cities.
Table 6. Spatial Distribution and Capacity Gradient Statistics of Leading Enterprises in the Three Cities.
CityNumber and Proportion (%) of Leading Enterprises Within the City AreaCore-Periphery Capacity Gradient Characteristics
Core ZoneSecondary ZonePeripheral Zone
Beijing47.234.118.7Moderate, multi-polar interaction
Shanghai65.923.011.1Steep, unipolar core leadership
Wuhan72.819.67.6Extremely steep, single-core dominance
Table 7. Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine in the Three Cities.
Table 7. Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine in the Three Cities.
CityBeijingShanghaiWuhan
Spatial Organization Logic
Core FunctionNetwork Synergy HubCore Function EnhancerRegional Capacity Upgrading Anchor
Spatial StructurePolycentric, NetworkedUnipolar Leadership, Multi-District CollaborationSingle-Core, Axial Expansion
Development DriverKnowledge and Policy Dual-DriveMarket and Globalization DrivenStrong Policy Planning Driven
Leading Enterprise DistributionMulti-Polar Interaction (Changping-Daxing Dual Core)Unipolar Core Leadership (High Agglomeration in Pudong)Single-Core Dominance (Optics Valley Biolake)
Evolution PathPeripheral Incubation—Center Polarization—Network SynergyUnipolar Initiation—Multi-Polar Expansion—Functional IntegrationDispersed Germination—Policy-Driven—Structural Lock-In
Table 8. Construction Mode Typology for Biomedical Pilot-Scale Bases.
Table 8. Construction Mode Typology for Biomedical Pilot-Scale Bases.
Mode TypeCore FunctionDriving ForceSpatial StructureConstruction & Operation Focus
Network Synergy TypeNetwork Synergy HubPromotes knowledge flow and functional complementarity among multiple polesPolycentric network typeOpen sharing, strengthened connectivity
Core-Embedded TypeCore Function EnhancerMeets intensive, cutting-edge pilot-scale demands within high-capacity poles to consolidate competitive advantageUnipolar radial typeSpecialization, high-end orientation, scale, marketization
Policy-Anchored TypeRegional Capacity Upgrading AnchorServes as public infrastructure to attract and nurture industrial clustersSingle-core agglomeration typeFoundational, inclusive, support for key generic technologies
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Guan, M.; Cheng, F. Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine from an Urban Heterogeneity Perspective: A Multiple-Case Comparison Based on Innovation Clusters in China. Urban Sci. 2026, 10, 234. https://doi.org/10.3390/urbansci10050234

AMA Style

Guan M, Cheng F. Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine from an Urban Heterogeneity Perspective: A Multiple-Case Comparison Based on Innovation Clusters in China. Urban Science. 2026; 10(5):234. https://doi.org/10.3390/urbansci10050234

Chicago/Turabian Style

Guan, Mengran, and Fangxin Cheng. 2026. "Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine from an Urban Heterogeneity Perspective: A Multiple-Case Comparison Based on Innovation Clusters in China" Urban Science 10, no. 5: 234. https://doi.org/10.3390/urbansci10050234

APA Style

Guan, M., & Cheng, F. (2026). Spatial Organization Logic and Typology of Shared Pilot-Scale Bases in Biomedicine from an Urban Heterogeneity Perspective: A Multiple-Case Comparison Based on Innovation Clusters in China. Urban Science, 10(5), 234. https://doi.org/10.3390/urbansci10050234

Article Metrics

Back to TopTop